Ardelyx (ARDX)
(Delayed Data from NSDQ)
$5.99 USD
-0.05 (-0.83%)
Updated Oct 14, 2024 03:59 PM ET
After-Market: $6.00 +0.01 (0.17%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth A Momentum C VGM
Price, Consensus and EPS Surprise
ARDX 5.99 -0.05(-0.83%)
Will ARDX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for ARDX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ARDX
Wall Street Analysts Think Ardelyx (ARDX) Could Surge 65.4%: Read This Before Placing a Bet
Here's What Key Metrics Tell Us About Ardelyx (ARDX) Q2 Earnings
ARDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates
Will BioCryst Pharmaceuticals (BCRX) Report Negative Earnings Next Week? What You Should Know
Ardelyx (ARDX) Expected to Beat Earnings Estimates: Should You Buy?
Other News for ARDX
Ardelyx announces publication of review article on IBS-C
Ardelyx Inc (ARDX) Q2 2024 Earnings Call Highlights: Revenue Surge and Strategic Challenges
Class Action Lawsuit Against Ardelyx, Inc. (NASDAQ:ARDX)
Piper Sandler Remains a Hold on Ardelyx (ARDX)
Hope and Healing: The Role of Media in Uplifting Spirits During Life's Toughest Moments of Kidney Disease